The Latest In Critical Care, 9/23/24 (#57)
Optimal oxygen dose duration; High vs low BiPAP pressures for COPD exacerbations; Assessing for fraud in Chinese clinical trials
Links:
The Truth about China’s Cash-for-Publication Policy, MIT Technology Review, July 2017
“Why Fake Research Is Rampant in China,” The Economist, February 2024
The End of Publish or Perish? China’s New Policy on Research Evaluation, Max Planck Institute
Five ways China must cultivate research integrity, Nature, November 2019
Nearly half of US Chinese student dismissals due to “academic dishonesty”, The PIE, September 2023
Dana-Farberications at Harvard University, For Better Science, January 2024
How Much Scientific Research Is Actually Fraudulent? Reason, July 2021